• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Science
  • For Patients
  • For Providers
    • Reimbursements
  • About
  • Contact Us
  • Request Information

We’re transforming wound care with bioactive glass.

Request Information

Intentional engineering

We lead with compassion, believing that engineering, no matter how advanced, is only as valuable as the people it helps.

Focusing on peace of mind

We aim to deliver safe, effective and efficient wound care solutions that bring providers and patients peace of mind.

Empowering the body to heal itself

We harness the power of elements, engineered as bioactive glass, to offer an unparalleled solution in wound care.

Leadership Team

Contact

Nicolas Guggenheim

CEO ETS

Christine Grogan

Head of Wound Care

Steve Jung

Chief Technology Officer

Robert Richter

Chief Financial Officer

Mitch Lark

Chief Operating Officer

Melissa Miller

Head of Human Resources, Compliance Officer

Donnie Buck

Chief Medical Officer

Built to support healing.

MirragenĀ® is a product of Engineered Tissue Solutions (ETS). a company dedicated to developing medical products composed of proprietary borate-based bioactive glass. Mirragen is the first FDA-cleared inorganic bioactive glass based wound care solution.

Our Patented Technology

ETS was acquired in 2021 by the Heraeus Group, a broadly diversified family-owned technology company. Learn more about Heraeus Group at www.heraeus.com.

Learn how Mirragen is transforming wound care.

Request Information
  • Request Information
  • Contact Us
  • Careers
  • VTail
  • Twitter
  • Facebook
  • LinkedIn
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care